Ambien is the brand name for zolpidem, a prescription sedative-hypnotic used for short-term treatment of insomnia characterized by difficulty falling asleep. Zolpidem is often grouped with eszopiclone and zaleplon as a “Z-drug.” It is not a benzodiazepine, but it enhances inhibitory GABA signaling through the GABA-A receptor complex and can produce sedation, impaired coordination, memory problems, physical dependence and misuse.
Ambien is federally classified as a Schedule IV controlled substance. Current U.S. labeling carries an FDA boxed warning for complex sleep behaviors, including sleepwalking, sleep-driving and other activities performed while not fully awake. Serious injuries and deaths have occurred. The warning applies even when zolpidem is used at recommended doses, and a history of a complex sleep behavior after zolpidem is a contraindication to using it again.
Ambien should not be understood as a harmless sleep aid simply because it is prescribed. Its effects can extend into the next morning, particularly when blood levels remain high, when a person does not have enough time for a full night’s sleep, when alcohol or other CNS depressants are involved, or when zolpidem clearance is slower.
Ambien at a Glance
| Generic name | Zolpidem tartrate |
| Drug class | Sedative-hypnotic, commonly called a Z-drug |
| Federal schedule | Schedule IV |
| Primary labeled use | Short-term treatment of insomnia characterized by difficulty with sleep initiation |
| Immediate-release half-life | About 2.5 to 2.6 hours on average in healthy adults |
| Major boxed warning | Complex sleep behaviors such as sleepwalking and sleep-driving |
| Important next-day risk | Impaired alertness, coordination and driving ability |
| Dependence risk | Physical and psychological dependence can occur; risk increases with dose and duration |
| High-risk combinations | Alcohol, opioids, benzodiazepines and other CNS depressants |
What Does Ambien Do?
Zolpidem slows activity in the brain through GABA-related signaling. GABA is the brain’s major inhibitory neurotransmitter. Increasing inhibitory signaling makes it easier for many people with insomnia to fall asleep.
That same mechanism explains why zolpidem can impair memory, reaction time, coordination and judgment. A medicine that suppresses wakefulness cannot selectively affect only the part of the brain responsible for sleep onset. Other cognitive and motor functions can be affected as well.
Is Ambien a Benzodiazepine?
No. Ambien is not chemically a benzodiazepine. Zolpidem is usually described as a non-benzodiazepine sedative-hypnotic or Z-drug.
The distinction is chemically accurate, but it should not be interpreted as meaning zolpidem has none of the safety issues associated with sedative drugs. Both zolpidem and benzodiazepines can cause CNS depression, impaired coordination, tolerance, physical dependence and withdrawal. Combining them can intensify sedation.
See Ambien and Xanax for the interaction between zolpidem and alprazolam.
How Quickly Does Ambien Work?
Current Ambien pharmacokinetic labeling reports a mean time to peak concentration of about 1.6 hours after immediate-release tablets in healthy subjects. The medication is intended to be taken immediately before going to bed when the person can remain in bed for a full night.
Food can delay the time to peak concentration and reduce peak levels. This is why labeling advises against taking Ambien with or immediately after a meal when rapid sleep onset is desired.
How Long Does Ambien Last?
The average elimination half-life of immediate-release Ambien is approximately 2.5 to 2.6 hours in healthy adults. A half-life describes how quickly blood concentration falls, not exactly how long sedation or impairment lasts.
Next-day impairment can occur even when a person feels awake. FDA has specifically warned that residual zolpidem levels can impair activities requiring full alertness, including driving.
See How Long Does Ambien Last? for a detailed distinction between half-life, sleep effect and next-day impairment.
Ambien vs. Ambien CR
Immediate-release Ambien releases zolpidem rapidly and is labeled for sleep-initiation insomnia. Ambien CR is an extended-release product with biphasic absorption. It produces an initial release followed by more sustained zolpidem concentrations later in the night.
Ambien CR does not simply have a dramatically longer terminal half-life. Current labeling reports that its terminal half-life is similar to immediate-release zolpidem, while plasma concentrations remain extended beyond three hours because of the release design.
See Ambien CR vs Ambien for the full comparison.
Why FDA Lowered Zolpidem Dose Recommendations
FDA reviewed driving-simulation and blood-level data showing that some patients had zolpidem concentrations the next morning high enough to impair driving. Women, on average, clear zolpidem more slowly than men and were more likely to have higher residual levels.
FDA therefore required lower recommended initial doses for women and encouraged use of the lowest effective dose. This is a population-level safety measure. It does not mean every man clears zolpidem quickly or every woman has next-day impairment.
What Are Complex Sleep Behaviors?
Complex sleep behaviors occur when someone gets out of bed and performs activities while not fully awake. Reported behaviors include:
- Sleepwalking
- Sleep-driving
- Preparing or eating food
- Making phone calls
- Having sex
- Other activities requiring coordination or judgment
People often have no memory of the event afterward. FDA requires a boxed warning because serious injuries and deaths have occurred.
See Ambien Sleepwalking and Complex Sleep Behaviors for the dedicated safety guide.
Common Ambien Side Effects
Commonly reported effects include drowsiness, dizziness, headache, a drugged feeling, reduced coordination, balance problems and gastrointestinal symptoms. Some people report unusual dreams or memory problems.
The practical issue is not only whether a side effect feels unpleasant. A person who is dizzy, slowed or amnestic can fall, drive unsafely or make decisions without fully remembering them.
Can Ambien Affect Memory?
Yes. Zolpidem can impair memory formation, particularly around the period after a dose. A person may appear awake enough to talk, eat or move around while later having limited memory for those events.
Memory loss becomes especially concerning when it occurs with alcohol, other sedatives or complex sleep behavior.
Can Ambien Cause Next-Day Impairment?
Yes. FDA distinguishes next-morning impairment from complex sleep behavior. In next-day impairment, the person is awake but residual drug levels can still reduce reaction time, coordination and alertness.
People should not assume that feeling awake proves they are safe to drive. Extended-release zolpidem is particularly important because it maintains concentrations later into the night.
Can Ambien Cause Dependence?
Yes. Current DailyMed labeling states that Ambien can lead to physical and psychological dependence and that risk increases with dose and duration of treatment. People with a history of alcohol or drug misuse may have additional risk.
Physical dependence means that stopping suddenly or reducing exposure rapidly can produce withdrawal symptoms. It is not exactly the same as addiction.
Can Ambien Cause Addiction?
Yes. Zolpidem can be misused and can become part of a sedative use disorder. Warning signs can include taking more than prescribed, escalating use because the medication feels less effective, using it for reasons other than sleep, combining it with other substances, repeatedly running out early or continuing despite serious consequences.
See Ambien Addiction for a deeper discussion of misuse, dependence and treatment.
What Happens if Ambien Is Stopped Suddenly?
Withdrawal symptoms have been reported after rapid reduction or abrupt discontinuation. Current labeling describes a range from rebound insomnia and dysphoria to more serious sedative-hypnotic withdrawal symptoms. Convulsions and delirium are possible in severe withdrawal syndromes.
A person who has been taking zolpidem regularly should not create a taper from an online article. The appropriate discontinuation plan depends on exposure, duration, other sedatives, alcohol use, seizure history and medical conditions.
See Ambien Withdrawal.
Ambien and Alcohol
Alcohol and zolpidem both depress the central nervous system. Current labeling advises people not to take Ambien if they drank alcohol that evening or before bed. Alcohol can worsen sleepiness, psychomotor impairment and abnormal behavior.
See Ambien and Alcohol.
Ambien and Opioids
Zolpidem can add to the respiratory-depressant effects of opioids. Current labeling warns that potentially serious additive effects can occur when Ambien is used with opioids.
A person who is difficult to wake or breathing slowly after using zolpidem with an opioid needs emergency evaluation. Naloxone can reverse the opioid component but does not reverse zolpidem.
Ambien and Depression
Zolpidem labeling warns about worsening depression and suicidal thinking. Insomnia itself is also closely linked with depression and other psychiatric conditions.
If insomnia persists, worsens or is accompanied by major mood changes, clinicians should evaluate whether an underlying medical or psychiatric condition is contributing rather than simply escalating sleep medication.
Who May Have Higher Zolpidem Exposure?
Age, sex, liver function and interacting medications can affect exposure. Older adults have shown higher concentrations and longer half-life in pharmacokinetic studies. Liver impairment can have an even larger effect. In one labeling study, the mean half-life in cirrhotic patients was about 9.9 hours compared with about 2.2 hours in healthy controls.
This does not mean a reader should calculate their own dose. It explains why prescribing recommendations differ across patient groups.
How Is Ambien Different From Lunesta?
Ambien contains zolpidem. Lunesta contains eszopiclone. Both are Schedule IV Z-drugs and both carry the FDA boxed warning for complex sleep behaviors.
Eszopiclone is labeled for insomnia including sleep onset and maintenance. Immediate-release Ambien is labeled for sleep-initiation insomnia. Their pharmacokinetics and next-day effects also differ.
See Ambien vs Lunesta.
Is Trazodone the Same Type of Sleep Medicine?
No. Trazodone is an antidepressant approved for major depressive disorder. It is often prescribed off-label for insomnia because it can be sedating, but its FDA-approved indication is not insomnia.
See Ambien vs Trazodone for Sleep.
When to Seek Emergency Help
Seek urgent help for inability to wake, severe breathing difficulty, collapse, seizure, suspected overdose, serious injury during a complex sleep behavior, severe allergic swelling or suicidal behavior.
If an opioid may also be involved and breathing is slow or stopped, give naloxone if available while emergency services are being contacted.
Frequently Asked Questions About Ambien
What is Ambien?
Ambien is a brand of zolpidem, a Schedule IV sedative-hypnotic used for short-term treatment of insomnia with difficulty falling asleep.
Is Ambien a benzodiazepine?
No. Zolpidem is a non-benzodiazepine Z-drug, although it acts through GABA-related signaling and shares several sedative risks with benzodiazepines.
How long is Ambien’s half-life?
Current labeling reports an average immediate-release half-life of about 2.5 to 2.6 hours in healthy adults.
Can Ambien be addictive?
Yes. Zolpidem can be misused and can cause physical or psychological dependence.
Why does Ambien have a boxed warning?
FDA requires the warning because complex sleep behaviors such as sleepwalking and sleep-driving have caused serious injuries and deaths.
Sources
- DailyMed: Ambien (zolpidem tartrate), current Sanofi labeling: boxed warning, indications, pharmacokinetics, dependence, withdrawal, overdose and drug interactions.
- FDA: Taking Z-drugs for Insomnia? Know the Risks: current FDA safety overview for zolpidem, eszopiclone and zaleplon.
- FDA: Boxed Warning for Complex Sleep Behaviors: sleepwalking, sleep-driving and other activities while not fully awake.
- FDA: Next-Morning Impairment With Zolpidem: residual blood levels, driving risk and sex-related clearance differences.
- MedlinePlus: Zolpidem: patient information on insomnia treatment, dependence, withdrawal, alcohol, next-day impairment and complex sleep behavior.
About This Article
Editorial standard
Rehabs.Today resource articles are written for educational and treatment-navigation purposes. For medical and drug-safety claims, we prioritize current primary or authoritative references such as FDA and DailyMed labeling, CDC, SAMHSA, NIH/NCBI resources, and peer-reviewed research when appropriate. Important limitations, uncertainty, and differences between population-level evidence and individual medical advice are stated where they matter.
How to use this information
This article provides general educational information. It is not a diagnosis, prescription, personalized taper, or substitute for advice from a physician, pharmacist, or other qualified healthcare professional. Do not start, stop, combine, or change a prescribed medication solely because of information on this page.
Emergency information
If someone cannot be awakened, is breathing slowly or abnormally, or may be experiencing an opioid overdose, seek emergency medical help immediately and give naloxone if it is available.
Treatment-directory transparency
Some Rehabs.Today articles link to treatment directories and provider resources. Those links are for navigation and do not replace independent medical assessment. Medical claims in the article should be evaluated from the cited evidence, not from whether a treatment provider is linked.